CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Resnitzky, D.
Right arrow Articles by Kimchi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Resnitzky, D.
Right arrow Articles by Kimchi, A.

Cell Growth & Differentiation, Vol 2, Issue 1 33-41, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells

D Resnitzky and A Kimchi
Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.

The proliferation of M1 myeloblastic cells can be specifically restricted at the G0/G1 phase of the cell cycle by exposure to alpha- and beta-interferons or to interleukin 6. The latter cytokine also induces the morphological and functional differentiation of these myeloblasts toward monocytes. Each of these two different cytokines suppresses the expression of the c-myc nuclear oncogene, and the selective reduction in c-myc mRNA and protein precedes the cell cycle changes. In order to investigate whether one or more of the growth-suppressive effects of interferon and interleukin 6 are mediated by c-myc reduction, M1 cells were transfected with SV40-driven c-myc plasmid, whose expression fails to be turned off by these two cytokines. A detailed analysis of the responses to interferon and to interleukin 6 revealed that all of the myc-transfected clones have lost the cytokine-mediated G0/G1 type of growth arrest. However, not all of the growth responses to these cytokines were rescued by this specific genetic manipulation, and the cytokine-treated transfected cells stopped to proliferate in a new fashion which was not cell cycle specific. In addition, the myc-transfected cells developed the differentiated phenotype in response to interleukin 6, as determined by the morphological change, expression of Fc receptors, and cytochemical analysis, suggesting that these molecular events can occur in the monocyte cell lineage in spite of the abnormal constitutive expression of c-myc.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Br J OphthalmolHome page
P N Tulley, M Neale, D Jackson, J S Chana, R Grover, I Cree, A O Grobbelaar, and G D Wilson
The relation between c-myc expression and interferon sensitivity in uveal melanoma
Br J Ophthalmol, December 1, 2004; 88(12): 1563 - 1567.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
C. V. Ramana, N. Grammatikakis, M. Chernov, H. Nguyen, K. Chuan Goh, B. R. G. Williams, and G. R. Stark
Regulation of c-myc expression by IFN-{gamma} through Stat1-dependent and -independent pathways
EMBO J., January 17, 2000; 19(2): 263 - 272.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Raveh, A. G. Hovanessian, E. F. Meurs, N. Sonenberg, and A. Kimchi
Double-stranded RNA-dependent Protein Kinase Mediates c-Myc Suppression Induced by Type I Interferons
J. Biol. Chem., October 11, 1996; 271(41): 25479 - 25484.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L P Deiss, E Feinstein, H Berissi, O Cohen, and A Kimchi
Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.
Genes & Dev., January 1, 1995; 9(1): 15 - 30.
[Abstract] [PDF]


Home page
ScienceHome page
L. Deiss and A Kimchi
A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal
Science, April 5, 1991; 252(5002): 117 - 120.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.